Vident Investment Advisory’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,352
Closed -$257K 59
2023
Q2
$257K Buy
+2,352
New +$223K 0.01% 955
2023
Q1
Sell
-2,104
Closed -$216K 1238
2022
Q4
$216K Sell
2,104
-19,876
-90% -$2.29M 0.01% 1010
2022
Q3
$2.22M Buy
+21,980
New +$2.41M 0.07% 312
2020
Q3
Sell
-27,748
Closed -$1.25M 871
2020
Q2
$1.25M Sell
27,748
-4,465
-14% -$214K 0.07% 399
2020
Q1
$1.86M Sell
32,213
-1,810
-5% -$124K 0.12% 187
2019
Q4
$2.12M Buy
+34,023
New +$2.01M 0.13% 240
2019
Q2
Sell
-38,289
Closed -$1.8M 455
2019
Q1
$1.8M Sell
38,289
-9,607
-20% -$533K 0.1% 311
2018
Q4
$2.71M Sell
47,896
-4,114
-8% -$231K 0.15% 141
2018
Q3
$2.85M Sell
52,010
-14,028
-21% -$803K 0.11% 253
2018
Q2
$3.87M Buy
66,038
+990
+2% +$59.1K 0.15% 129
2018
Q1
$4.27M Buy
+65,048
New +$3.54M 0.17% 91
2015
Q4
Sell
-15,384
Closed -$462K 395
2015
Q3
$462K Sell
15,384
-3,893
-20% -$128K 0.06% 559
2015
Q2
$609K Buy
19,277
+1,043
+6% +$27.2K 0.08% 370
2015
Q1
$421K Sell
18,234
-3,345
-16% -$69.2K 0.08% 516
2014
Q4
$423K Buy
+21,579
New +$371K 0.14% 315

Other funds holding AMN

Vident Investment Advisory's AMN Position: Q3 2023 in Review

Vident Investment Advisory sold out of AMN Healthcare (AMN) in Q3 2023, closing a stake of 2,352 shares — an estimated $257K sold.

Vident Investment Advisory first reported a position in AMN in Q4 2014 and held it in 15 quarters. The position peaked at $4.27M in Q1 2018. 388 funds tracked by Wall St. Rank hold AMN as of Q3 2023.

  • Vident Investment Advisory reported no remaining AMN Healthcare position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 2,352 AMN Healthcare shares in Q3 2023, an estimated $257K.
  • Vident Investment Advisory first reported a position in AMN Healthcare in Q4 2014 and held it in 15 quarters.
  • Vident Investment Advisory's AMN Healthcare position peaked at $4.27M in Q1 2018.
  • 388 funds tracked by Wall St. Rank held AMN Healthcare as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.